¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"concentration camp syndrome"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
¿µ¹® organic brain syndrome ÇÑ±Û ±âÁúÀû ³úÁõÈıº
¼³¸í   
  ³úÀÇ ±âÁúÀûÀÎ(organic-:ÀÌ ¸»Àº ±â´ÉÀûÀÎ(functional)¿¡ ¹ÝÇϴ ¸»·Î½á) ¸ðµç °Ë»ç¸¦ ½ÃÇàÇϸ頾 ÀÌ»óÀ» ¹ß°ßÇÒ ¼ö Àִٴ ¶æÀÌ´Ù. ¹Ù²Ù¾î ¸»Çϸé, ±â´ÉÀûÀΠÀ̻󿡠ÀÇÇÑ ³úÁõÈıºÀº ¾î¶°ÇÑ °Ë»ç·Îµµ ÀÌ»óÀ» ¹ß°ßÇÒ ¼ö ¾øÀ¸³ª ºÐ¸íÈ÷ È¯ÀÚ¿¡°Ô ÀÌ»óÁõ»óÀÌ ³ªÅ¸³µÀ» ¶§ À̸¦ ¹­¾î¼­ ¸»ÇÑ´Ù. À̻󿡠ÀÇÇØ ½Å°æÇÐÀûÀΠÀÌ»óÀ» ³ªÅ¸³»´Â ÀÏ·ÃÀÇ º´ÀûÇö»óÀ» ¸ðµÎ ÅëÆ²¾î ¸»ÇÑ´Ù. ÀÌ º´Àº ÈçÈ÷ º¸¾Æ ¸¶Ä¡ Á¤½Åº´È¯ÀÚó·³ ¸»À» È¾¼³¼ö¼³Çϰí, ¾Ë¾ÆµéÀ» ¼ö ¾ø´Â ¸»À» Çϸç, ¶§·Î´Â ´Ù¸¥ »ç¶÷¿¡°Ô °ø°ÝÀûÀΠ¼ºÇâÀ» ³ªÅ¸³»±âµµ ÇÑ´Ù. ±×¸®°í ´Ù¸¥ »ç¶÷°ú µµÀúÈ÷ ±³·ù¸¦ ÇÒ ¼ö ¾ø´Â Á¤¼­¸¦ ³ªÅ¸³»±âµµ ÇÑ´Ù. ±×·¯³ª, ÀÌ º´ÀÌ ´Ù¸¥ Á¤½Åº´°ú ±¸º°µÇ´Â Æ¯Â¡ÀûÀΠÁõ»óÀº ¸ÕÀú, ÀǽÄÀǠȥŹÀÌ µ¿¹ÝµÇ´Â °æ¿ì°¡ ¸¹°í, ¶ÇÇÑ ±× Áõ»óÀÇ Á¤µµ°¡ º¯ÇѴٴ °ÍÀÌ´Ù. Áï, ¾ÆÄ§¿¡´Â Á¤»óÀûÀΠÇൿÀ» ÇÏ´Ù°¡ ¿ÀÈİ¡ µÇ¸é, ÀǽÄÀÌ Èå·ÁÁö¸é¼­ ¸»À» È¾¼³¼ö¼³ÇÑ´Ù¸é, À̴ ±âÁú¼º³úÁõÈıºÀÏ °¡´É¼ºÀÌ ³ô´Ù.
¿µ¹® Down syndrome ÇÑ±Û ´Ù¿îÁõÈıº
¼³¸í   
  »ç¶÷ÀÇ 46°³ ¿°»öü Áß Á¦ 21¹ø ¿°»öüÀÇ ¼ö°¡ 1°³ ´õ ¸¹¾ÆÁö¹Ç·Î½á ³ªÅ¸³ª´Â º´ÀÌ´Ù. È¯ÀÚÀÇ »ý±è»õ°¡ ¸¶Ä¡ ¸ù°í »ç¶÷°ú ´à¾Ò´Ù ÇÏ¿© ÀÏ¸í ¸ù°íÁõ(mongolism)À̶ó°í ÇÏ¿´À¸³ª À߸øµÈ À̸§ÀÌ´Ù. ÀÌ º´Àº ¹Ýµå½Ã 21¹ø ¿°»öü°¡ 3°³°¡ µÇ´Â °æ¿ìÀ̿ܿ¡µµ 21¹ø ¿°»öüÀÇ ÀϺκÐÀÌ ´Ù¸¥ ¿°»öüÀÇ ÀϺκаú ±³È¯ÀÌ µÇ´Â translocationÇü µîÀÇ ´Ù¸¥ ¿°»öüÀ̻󿡼­µµ º¼ ¼ö°¡ ÀÖ´Ù. ¹ß»ý ºóµµ´Â Ãâ»ý¾Æ 700~1000¸íÁß 1¸í ²Ã·Î ³ªÅ¸³ª¸ç, ¿°»öü À̻󺴠Áß¿¡ °¡Àå ¸¹Àº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ÀÌ º´ÀÇ ¹ß»ýºóµµ´Â »ê¸ðÀÇ Ãâ»ê¿¬·É°ú ¹ÐÁ¢ÇÑ °ü°è°¡ ÀÖ¾î, 35¼¼ ÀÌÈİ¡ µÇ¸é ±âÇÏ ±Þ¼öÀûÀ¸·Î ÀÌ ÁúȯÀÚÀÇ Ãâ»ê¼ö°¡ Áõ°¡ÇÑ´Ù. ÀϹÝÀûÀ¸·Î ÀÌ Áúȯ¿¡ À־ ¾à 3ºÐÀÇ 1Àº ¸ðÄ£ÀÇ Ãâ»ê¿¬·É¿¡ ÀÇÁ¸ÇÏÁö ¾Ê°í, ³ª¸ÓÁö ¾à 3ºÐÀÇ 2´Â ¸ðÄ£ÀÇ ¿¬·É°ú Á÷Á¢ °ü·ÃÀÌ Àִ °ÍÀ¸·Î º¸°í ÀÖ´Ù. Áø´ÜÀº Æ¯Â¡ÀûÀΠ»ý±è»õ, Áï ¸ù°í »ç¶÷°°ÀÌ ´«²¿¸®°¡ À§·Î Ä¡ÄÑÁ® ÀÖ°í ´«°ÅÇ®ÀÌ µÎ²¨¿ì¸ç ÄàµîÀÌ ³·Àº Æ¯Â¡ÀûÀΠ¾ó±¼ ¸ð½À, ¶ÇÇÑ ±ÙÀ°ÀÇ ±äÀåµµ°¡ ÀúÇϵǰí Á¥À» ºü´Â Èû°ú ¿ïÀ½ ¼Ò¸®°¡ ¾àÇϸ砼չٴÚÀÇ Á¿츦 °¡¸£´Â ÇÑÁÙÀÇ ¼Õ±Ý(¿ø¼þÀ̿͠°°Àº ÇüÅÂÀÌ´Ù) µîÀǠƯ¡ÀûÀΠ¼Ò°ß¿¡ ÀÇÇØ º¸Á¶Áø´ÜÀ» Çϰí ÃÖÁ¾ÀûÀ¸·Î ¿°»öü ºÐ¼®¿¡ ÀÇÇØ È®ÁøÀ» ÇÑ´Ù. ÀÌ ´Ù¿îÁõÈıºÀǠȯÀڴ ´ë°³ Áö´ÉÀÌ ÀúÇϵǾî ÀÖ°í, ¿©·¯ °¡Áö Á¾·ùÀÇ ¼±Ãµ¼º ½ÉÀå±âÇüÀ» ¸¹ÀÌ µ¿¹ÝÇϰí ÀÖ´Ù.
¿µ¹® dumping syndrome ÇÑ±Û ´ýÇÎÁõÈıº
¼³¸í   
  ºÎºÐÀû À§ÀýÁ¦¼ú ¶Ç´Â À§ºóâÀÚ¿¬°á¼úÀ» ¹ÞÀº È¯ÀÚ¿¡°Ô¼­ À½½ÄÀ» ¸ÔÀº ÈÄ¿¡ ÀϾ´Â ÁõÈıºÀÌ´Ù. ¸íÄ¡ ºÎºÐÀÇ ÆØ¸¸°¨°ú ¾Ð¹Ú°¨-±¸¿ª-±¸Åä µîÀÇ º¹ºÎÁõ»ó ¿Ü¿¡ Å»·Â°¨-Çö±âÁõ-¹ßÇÑ-°¡½¿¶ê µî ¼øÈ¯Àå¾Ö Áõ»óÀÌ µû¸¥´Ù. ±×·± Áõ»óÀº ¼·ÃëÇÑ À½½Ä¹°ÀÌ À§¿¡¼­ ÀÛÀºÃ¢ÀڷΠÃß¶ôÇÏµí ¹èÃâµÊÀ¸·Î½á À½½Ä¹°ÀÇ ¹«°Ô·Î ÀÎÇØ ¼ÒÈ­°üÀÌ ¾Æ·¡ÂÊÀ¸·Î ÃÄÁ®µç´Ù. ÀÛÀºÃ¢ÀÚº®ÀÌ ±Þ°ÝÇϰԠ´Ã¾î³ªµç°¡, È­ÇÐÀû ÀÚ±ØÀ¸·Î ÀÎÇÑ ÀÛÀºÃ¢ÀÚº®ÀÇ ÀÚÀ²½Å°æ¹Ý»ç, ÀÛÀºÃ¢ÀÚº®ÀÇ »ïÅõ¾Ð¿¡ ÀÇÇØ ¼ÒÈ­°üÀ¸·Î ¼öºÐÀÌ ±Þ¼ÓÈ÷ ´ë·® À̵¿ÇÏ¿© ¼øÈ¯µÇ´Â Ç÷¾×ÀÇ ¾çÀÌ °¨¼ÒÇÏ¿© ÀϾ´Ù. ÁַΠ½Ä»ç¿ä¹ýÀ¸·Î Ä¡·áÇÏ¿©, ¾à¹°¿ä¹ýÀ¸·Î´Â ¾ÆÆ®·ÎÇÉ-Çí»ç¸ÞÅä´½-Æä³ë¹Ù¸£ºñÅ»-ź»ê¼ö¼Ò³ªÆ®·ýÀÇ »ç¿ë ¹× Æ÷µµ´çÁֻ絵 È¿°ú°¡ ÀÖ´Ù. ¼ö¼ú¿ä¹ýÀº ºô·Î½º(Billroth) Á¦1¹ýÀ¸·ÎÀÇ º¯È¯, ´ë¿ëÀ§ÀÇ Á¦ÀÛ µîÀÌ ÀÖÀ¸³ª È®½ÇÇÑ °ÍÀº ¾Æ´Ï´Ù.
¿µ¹® Raynaud syndrome ÇÑ±Û ·¹À̳ëÁõÈıº
¼³¸í   
  »çÁöÀÇ ´ëĪÀû Ã»»öÁõÀ» Æ¯Â¡À¸·Î Çϴ Áõ»óÀ¸·Î¼­ ¼Õ°¡¶ô-¼Õ¸ñ µîÀÇ ÇǺΰ¡ Áö¼ÓÀûÀ¸·Î Ã»»ö°ú Àû»öÀ¸·Î º¯Çϰí, ¼Õ°¡¶ôÀÇ ´ë·® ¶¡³²°ú ³Ã°¢À» ¼ö¹ÝÇÑ´Ù.
¿µ¹® battered child syndrome ÇÑ±Û ¸Å¸Â´Â ¾ÆÀÌ ÁõÈıº
¼³¸í   
  ¿µÀ¯¾Æ³ª ¼Ò¾Æ°¡ ºÎ¸ð µîÀÇ º¸À°ÀÚ³ª ÇüÁ¦ÀڸŷκÎÅÍ ¹Ýº¹Çؼ­ ½ÅüÀûÀΠÇд븦 ¹Þ¾Æ ¹ß»ýÇϴ °¢Á¾ Áõ»çÀÇ ÃÑĪÀÌ´Ù. 1962³â ÄÍÇÁ(Kempe)¿¡ ÀÇÇØ ¸í¸íµÇ¾ú´Ù. »ó󸦠¹ÞÀº ½Ã±â°¡ ¼­·Î Â÷À̰¡ Àִ ¿Ü»óÀÌ ¸ö Àüü ¿©·¯ °÷¿¡¼­ °üÂûµÇ´Â °ÍÀ̠Ư¡ÀÌ´Ù. ÇǺÎÀÇ ¼Õ»ó°ú ¾ó·èÃâÇ÷, °æÁú¸·ÇÏ Ç÷Á¾, °ñÀý µîÀÌ ¸¹°í ±Ø´ÜÀûÀΠ°æ¿ì´Â ¿µ±¸Àû ³ú¼Õ»ó°ú Á×À½¿¡ À̸£´Â °æ¿ìµµ ÀÖ´Ù. Çд뵿±â´Â ÇÇÇØÀÚ ÀÔÀå¿¡¼­´Â À°Ã¼Àû-Á¤½ÅÀû ¹ßÀ°ºÎÀü, ½ÖµÕÀÌ, ±âÇü, ¹ãÁß¿¡ ¿ì´Â °Í, ¾ß´¢Áõ, Àå³­, ¹ÝÇ×Àû Åµµ µîÀÌ ÀÖÀ¸¸ç °¡ÇØÀÚ ÀÔÀå¿¡¼­´Â º¸À°ÀÚÀÇ ¾ÆÀÌ¿¡ ´ëÇÑ ¾ÖÁ¤°áÇ̰ú °úÀ× ±â´ë, À°¾Æ¿¡ ´ëÇÑ ¹«Áö, ÇüÁ¦Àڸſ¡ ´ëÇÑ ½Ã»ù, Á¤½Åº´, ½Å°æÁõ, Áö´ÉÀúÇÏ, ¾ËÄڿàÁßµ¶ µîÀÌ ÀÖ°í, ¶Ç »ýȰȯ°æÀÇ ÀÔÀå¿¡¼­´Â ºó°ï, ºÎºÎ ºÒÈ­, ÇÙ°¡Á·À̸鼭 »çȸÀûÀ¸·Î °í¸³µÈ °¡Á¤ µîÀ» µé ¼ö ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • minimal bactericidal concentration
    ÃÖ¼Ò»ì±Õ³óµµ
  • minimal blocking concentration
    ÃÖ¼ÒÂ÷´Ü³óµµ
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
  • minimal inhibitory concentration
    ÃÖÀú¾ïÁ¦³óµµ
  • molar concentration
    ¸ô³óµµ
  • maximum allowable concentration
    ÃÖ´ëÇã¿ë³óµµ
  • maximum permissible concentration
    ÃÖ´ëÇã¿ë³óµµ
  • mean corpuscular hemoglobin concentration
    Æò±ÕÀûÇ÷±¸Çì¸ð±Û·Îºó³óµµ
  • osmotic concentration
    »ïÅõ³óµµ
  • particle concentration fluorescence
    ÀÔÀÚ³óÃàÇü±¤
  • peak concentration time
    ÃÖ°í³óµµ½Ã°£
  • stress concentration
    ÀÀ·ÂÁýÁß
  • subanesthetic concentration
    ¸¶Ãë´úµÈ³óµµ, ¸¶Ãë¹Ø³óµµ, Áظ¶Ãë³óµµ
  • smoke concentration
    ¸Å¿¬³óµµ
  • urinary solute concentration
    ¿ä¿ëÁú³óµµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Cushing's syndrome
    Äí½ÌÁõÈıº
  • dialysis disequilibrium syndrome
    Åõ¼®ºÒ±ÕÇüÁõÈıº
  • dry eye syndrome
    ´«¸¶¸§ÁõÈıº
  • dumping syndrome
    ºü¸¥ºñ¿òÁõÈıº, ´ýÇÎÁõÈıº
  • fetal alcohol syndrome
    žƾËÄÚ¿ÃÁõÈıº
  • Floppy infant syndrome
    Àú±äÀ徯ÁõÈıº, ±äÀåÀúÇÏ¿µ¾ÆÁõÈıº
  • Ganser syndrome
    °£ÀúÁõÈıº
  • Goodpasture's syndrome
    ±ÂÆÄ½ºÃ³ÁõÈıº
  • Guillain-Barre syndrome
    (¢¡acute idiopathic polyneuritis) ±Þ¼ºÆ¯¹ß´Ù¹ß½Å°æ¿° , ±Þ¼ºÆ¯¹ß¿©·¯½Å°æ¿°
  • hemolytic uremic syndrome
    ¿ëÇ÷¿äµ¶ÁõÈıº
  • hemorrhagic fever with renal syndrome
    ÃâÇ÷¿­ÄáÆÏÁõÈıº
  • hepatorenal syndrome
    °£ÄáÆÏÁõÈıº
  • irritable bowel syndrome
    °ú¹Î´ëÀåÁõÈıº
  • Kallmann syndrome
    Ä®¸¸ÁõÈıº
  • Klinefelter's syndrome
    Ŭ¶óÀÎÆçÅÍÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • minimal alveolar concentration
    ÃÖ¼ÒÆóÆ÷³»³óµµ
  • minimal anesthetic concentration
    ÃÖ¼Ò¸¶Ãë³óµµ
  • minimal bactericidal concentration
    ÃÖ¼Ò»ì±Õ³óµµ
  • minimal blocking concentration
    ÃÖ¼ÒÂ÷´Ü³óµµ
  • minimal effective analgesic concentration
    ÃÖ¼ÒÈ¿°úÁøÅë³óµµ
  • minimal inhibitory concentration
    ÃÖÀú¾ïÁ¦³óµµ, ÃÖÀúÀúÁö³óµµ
  • molar concentration
    ¸ô³óµµ
  • osmotic concentration
    »ïÅõ³óµµ
  • smoke concentration
    ¸Å¿¬³óµµ
  • stress concentration
    ÀÀ·ÂÁýÁß
  • subanesthetic concentration
    ¸¶Ãë´úµÈ³óµµ, ¸¶Ãë¹Ø³óµµ
  • urinary solute concentration
    ¿ä¿ëÁú³óµµ
  • egg concentration technique
    Áý¶õ¹ý
  • particle concentration fluorescence
    ÀÔÀÚ³óÃàÇü±¤
  • peak concentration time
    ÃÖ°í³óµµ½Ã°£
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • inhibitory concentration, minimum (MIC)
    ¾ïÁ¦ÃÖ¼Ò³óµµ
  • plasma concentration
    Ç÷Àå³óµµ.
  • Browns syndrome->superior oblique tendon sheath syndrome
    ºê¶ó¿îÁõÈıº
  • Cowdens syndrome = multiple hamartoma syndrome
    ´Ù¹ß¼º °ú¿ÀÁ¾ ÁõÈıº
  • ICE syndrome=iridocorneal endothelial syndrome
    ȫä°¢¸·³»ÇÇÁõÈıº
  • Lowes syndrome->oculocerebrorenal syndrome
    ·Î¿ìÁõÈıº
  • PIE syndrome => pulmonary infiltration with eosinophilia syndrome
    È£»ê±¸Áõ°¡¼º ÆóħÀ± ÁõÈıº
  • Q-T prolongation syndrome ; long Q-T syndrome
    Q-T°£°Ý ¿¬ÀåÁõÈıº.
  • Raeders syndrome=>painful Horners syndrome
    ·¹ÀÌ´õÁõÈıº
  • Steiners syndrome [=curtius syndrome, facial hemi
    ¾È¸é¹Ý(ÂÊ)ºñ´ëÁõ
  • UGH syndrome->uveitis-glaucoma-hemorrhage syndrome
    À¯Áö¿¡ÀÌÃëÁõÈıº
  • A-V syndrome
    A-VÁõÈıº
  • Acquiered immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª °áÇÌÁõÈıº
  • Adams Stokes syndrome
    ¾Ö´ý½º-½ºÅäÅ©½ºÁõÈıº.
  • Albrights syndrome
    ¾Ëºê¶óÀÌÆ® ÁõÈıº(~ ñøý¦ÏØ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • concentration method
    ³óÃà¹ý
  • concentration procedure
    ³óÃà¹æ¹ý
  • concentration-response curve
    ³óµµ¹ÝÀÀ°î¼±
  • concentration<³ª> concentratio
    ³óµµ(ÒØöô), ³óÃà(ÒØõê), ÁýÁß(ó¢ñé).
  • critical micelle concentration =CMC
    ÃÖÀú ¹Ì¼¿ Çü¼º³óµµ.
  • effect concentration(=activity)
    À¯È¿³óµµ(êóüùÒØÓø)
  • equivalent concentration
    ´ç·®³óµµ.
  • food chain =biological concentration
    ½Äǰ¿¬¼â(¡­ææáð).
  • fractional concentration
    ºÐȹ³óµµ.
  • fractional concentration
    ºÐȹ³óµµ(ÝÂüñÒØÓø).
  • hemoglobin content/concentration
    Ç÷»ö¼ÒÇÔ·®/³óµµ
  • hydrogen ion concentration
    ¼ö¼ÒÀ̿³óµµ.
  • inhibitory concentration, minimum (MIC)
    ¾ïÁ¦ÃÖ¼Ò³óµµ
  • least concentration =LC
    ÃÖÀú³óµµ(õÌî¸ÒØöô).
  • least concentration time =LCT
    ÃÖÀú³óµµ½Ã°£(¡­ãÁÊà).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Sanfillipo's syndrome
    ¼¾Çʸ®Æ÷ ÁõÈıº(ñøý¦ÏØ)
  • simian acquired immune deficiency syndrome
    ¿ø¼þÀÌ ÈÄõ¼º¸é¿ª°áÇÌÁúȯ(ý­ô¸àõØóæ¹ÌÀù¹òðü´)
  • Zollinger-Ellison syndrome
    Á¹¸µ°Å-¿¤¸®½¼ ÁõÈÄ(ñøý¦)
  • active concentration
    Ȱ¼º³óµµ(üÀàõÒØÓø)
  • concentration
    ³óµµ(ÒØÓø)
  • concentration equilibrium constant
    "³óµµÆòÇü»ó¼ö(ÒØÓøøÁû¬ßÈâ¦), (ÔÒ) apparent equilibrium constant"
  • concentration gradient
    ³óµµ ±¸¹è(ÒØÓøÎþÛÕ)
  • concentration of enzymatic activity
    È¿¼ÒȰ¼º ³óµµ(ý£áÈüÀàõÒØÓø)
  • concentration work
    ³óµµÀÛµ¿(ÒØÓøíÂÔÑ)
  • constituent concentration
    ±¸¼º¹° ³óµµ(ϰà÷ÚªÒØÓø)
  • critical concentration
    "ÀÓ°è³óµµ(×üÍ£ÒØÓø),"
  • critical micelle concentration
    ÃÖÀú(õÌî¸) ¹Ì¼¿ Çü¼º³óµµ(û¡à÷ÒØÓø)
  • effective concentration
    À¯È¿ ³óµµ (êóüùÒØÓø)
  • enzyme concentration
    È¿¼Ò³óµµ (ý£áÈÒØÓø)
  • hydrogen ion concentration
    ¼ö¼Ò(â©áÈ)À̿ ³óµµ(ÒØÓø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Guillain-Barre syndrome
    ±æ¶û¹Ù·¹ÁõÈıº
  • hypogenetic lung syndrome
    Àú¹ß»ýÆóÁõÈıº
  • hypoplastic left heart syndrome
    Á½ɽÇÇü¼ººÎÀüÁõÈıº
  • idiopathic respiratory distress syndrome
    Ư¹ß¼ºÈ£Èí°ï¶õÁõÈıº
  • impingement syndrome
    Ãæµ¹ÁõÈıº
  • Klinefelter's syndrome
    Ŭ¶óÀÎÆçÅÍÁõÈıº
  • Klippel-Feil syndrome
    Ŭ¸®Æç-ÆäÀÏÁõÈıº
  • lateral recess syndrome
    ¿ÜÃøÇÔ¿äÁõÈıº
  • Loeffler's eosinophilic syndrome
    ·ÚÇ÷¯È£»ê±¸ÁõÈıº
  • malabsorption syndrome
    Èí¼öÀå¾ÖÁõÈıº
  • Marfan's syndrome
    ¸¶¸£ÆÎÁõÈıº
  • medial medullary syndrome
    ³»Ãø¿¬¼öÁõÈıº
  • Meniere's syndrome
    ¸Þ´Ï¿¡¸£ÁõÈıº
  • middle lobe syndrome
    Áß¿±ÁõÈıº
  • mucocutaneous lymph node syndrome
    ÇǺÎÁ¡¸·¸²ÇÁÀýÁõÈıº
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CS calf serum; campomelic syndrome; carcinoid syndrome; cardiogenic shock; caries-susceptible; carotid ...
PCS palliative care service; Patient Care System; patterns of care study; pelvic congestion syndrome; ph...
CAMP Cyclophosphamide, Adriamycin(Doxorubicin), Methotrexate, Procarbazine
cAMP cyclic Adenosine Mono-Phosphate
GnRH Gonadotropin Releasing Hormone  [HP 1898, 2034]
  = LHRH
  = Go...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
cAMP-dPK cAMP dependent protein kinase
cAMP PDE cAMP phosphodiesterase
CRP cAMP)-cAMP receptor protein
cAMP-PK cAMP)-dependent protein kinase
cAMP-kinase cAMP)-dependent protein kinase
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • A-V syndrome
    A-V ÁõÈıº
  • Aarskog syndrome
    ¾Æ¸£½ºÄÚ±× ÁõÈıº
    À¯Àü¼º ÁõÈıºÀÇ Çϳª·Î X-¿¬°ü¼º ÇüÁú·Î À¯ÀüµÈ´Ù. Ư¡À¸·Î´Â ¾È±¸ °Ý¸®Áõ, ³ÐÀº À­ ÀÔ¼ú, ¼î¿Ã, ÀÛÀº ¼Õ µîÀÌ ÀÖ´Ù. ¾È¸é ¼º±â Çü¼º Àå¾Ö
  • Aase syndrome
    ¾ÆÁî ÁõÈıº
    °æ¹ÌÇÑ ¼ºÀå Áö¿¬, ÀúÇü¼º ºóÇ÷, ´Ù¾çÇÑ ¹éÇ÷±¸ °¨¼ÒÁõ, ¼¼ °³·Î °¥¶óÁø ¾öÁö¹ß°¡¶ô, Á¼Àº ¾î±ú, ´ÊÀº õ¹® Æó¼â, ¾ðûÀÌ, ±¸°³ ÆÄ¿­, ¸Á¸·º´Áõ µîÀ» Ư¡À¸·Î ÇÏ´Â ÁõÈıºÀ¸·Î¼­ ¿­¼ºÀ¸·Î À¯ÀüµÇ´Â °ÍÀ¸·Î »ý°¢µÈ´Ù.
  • abnormal laterality syndrome
    ÁÂ¿ì ºñ´ëĪ ÀÌ»ó ÁõÈıº
    ½ÉÀå¿¡¼­ Á¤»óÀûÀÎ ÁÂ¿ì ´ëĪÀÌ µÚ¹Ù²î°Å³ª ºÒ¿ÏÀüÇÑ °æ¿ì·Î¼­, ÁÂÃøÀ̳ª ¿ìÃøÇüÀ¸·Î ´ëĪÀÎ °æ¿ì°¡ ÀÖ°í À̵鿡¼­ ¿©·¯ °¡Áö ½ÉÀå ±âÇüÀÌ µ¿¹ÝµÇ´Âµ¥ ÀÌ·¯ÇÑ °æ¿ì¸¦ ½ÉÀåÀÇ ÁÂ¿ì ºñ´ëĪ ÀÌ»ó ÁõÈıºÀ̶ó ÇÑ´Ù. À̵é Áúȯ¿¡¼­´Â ½ÉÀå »Ó ¾Æ´Ï¶ó ÁÖ ±â°üÁö¿Í »óÆóµ¿¸ÆÀÇ À§Ä¡ °ü°è ¹× ÆóÀÇ ºÐ¿±, °£°ú ºñÀåÀÇ ÇüÅ ¹× À§Ä¡°¡ ´Þ¶óÁö¸ç ƯÈ÷ ºñÀåÀÌ ¾ø´Â ¹«ºñÁõ
  • absent pulmonary valve syndrome
    Æó µ¿¸Æ ÆÇ °á¿© ÁõÈıº
    ´Üµ¶À¸·Î ÀϾ´Â °æ¿ì´Â ±ØÈ÷ µå¹°¸ç, ½É½Ç Áß°Ý °á¼Õ, ¿ì½Ç ´©µÎºÎ ÇùÂø¿¡ ÇÕº´ÇÏ´Â °æ¿ì°¡ ºñ±³Àû ¸¹´Ù. Áï Fallot 4ÁõÈÄÀÇ ÇÕº´ ±âÇüÀ¸·Î ³ªÅ¸³­´Ù. ÀÌ °æ¿ì ÁÂ¿ì Æóµ¿¸ÆÀÇ È®´ë, ¥±À½ Æóµ¿¸Æ ¼ººÐÀÇ ¿ÏÀü ¼Ò½Ç, ÇÇÄ¡°¡ ³·Àº È®Àå±â ÀâÀ½À» ³ªÅ¸³½´Ù. À̰ÍÀ» µ¿¹ÝÇÑ Fallot 4ÁõÈÄ´Â À¯¾Æ±â¿¡ ¿ïÇ÷¼º ½ÉºÎÀüÀ» ÀÏÀ¸Å°±â ½±´Ù.
  • absent testes syndrome
    °íȯ °á¿© ÁõÈıº
  • abstinence syndrome
    ±Ý´Ü ÁõÈıº
  • acid aspiration syndrome
    À§»ê ÈíÀÔ ÁõÈıº
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª °áÇÌ ÁõÈıº
    1. ÇöÀúÇÑ ¸é¿ª °áÇ̰ú ÇÔ²² ±âȸ°¨¿°, ¼Ó¹ß¼º ¾Ï ¹× ½Å°æ°è Áõ¼¼°¡ µ¿¹Ý. ¹ÙÀÌ·¯½º ÀÚü¿¡ ÀÇÇÑ º´º¯°ú ¸é¿ª´É·Â ÀúÇÏ¿¡ µû¸¥ ±âȸ °¨¿° µîÀÇ ÀÌÂ÷Àû º´º¯ÀÇ µÎ °¡Áö·Î ´ëº°. HIV¿¡ ÀÇÇØ ¹ß»ýµÇ´Â ÁúȯÀ¸·Î ½Å°æ°è°¡ Áß¿ä Ç¥ÀûÁß Çϳª. ¹ÙÀÌ·¯½º¿¡ °¨¿°µÈ »ç¶÷ÀÇ 40% Á¤µµ°¡ Áúº´ÀÌ ¹ß»ý. ¹ÙÀÌ·¯½ºÀÇ Á÷Á¢ÀûÀÎ ¿µÇâ¿¡ ÀÌÇÑ º´º¯À¸·Î´Â ¸²ÇÁ±¸¼º ¼ö¸·¿°°ú HIV ³ú¿° µîÀÌ ÀÖÀ½. 2. ÈÄõ¼º ¸é¿ª°áÇÌÁõ. Àΰ£ ¸é¿ª°áÇÌ ¹ÙÀÌ·¯½º
  • acquired immune deficiency syndrome
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • acute HIV infection syndrome
    ±Þ¼º ÀÎü ¸é¿ª °áÇÌ ¹ÙÀÌ·¯½º Áúȯ °¨¿° ÁõÈıº
  • acute muscle compartment syndrome
    ±Þ¼º ±Ù±¸¿ª ÁõÈıº
    °ñÀý, ºÎÁ¾, ÃâÇ÷¿¡ ´ëÇÑ ¼Ó¹ß¼ºÀ¸·Î ±Ù±¸¿ª³»ÀÇ ºÎÇǰ¡ ±Þ¼ºÀ¸·Î Áõ°¡ÇÏ¿© ¸ð¼¼Ç÷°üÀÌ ¾Ð¹ÚÀ» ¹Þ¾Æ ¹ß»ýÇÑ ±Ù±¸¿ª ÁõÈıº.
  • acute respiratory distress syndrome
    ±Þ¼º È£Èí°ï¶õ ÁõÈıº
    ¼ºÀΠȣÈíºÎÀü, ¼ï Æó, ¹Ì¸¸¼º ÆóÆ÷ ¼Õ»ó, ±Þ¼º ÆóÆ÷ ¼Õ»ó, ¿Ü»ó¼º ÀæÀº Æó µîÀÌ ÀÖ´Ù. ¹Ì¸¸¼ºÀ¸·Î ÆóÆ÷ ¸ð¼¼Ç÷°üÀÌ ¼Õ»óÀ» ÀÔ¾î ÃÊ·¡µÇ¸ç ÀÓ»óÀûÀ¸·Î´Â ±Þ°ÝÈ÷ »ý±ä ½ÉÇÑ È£Èí°ï¶õ, ºó¸Æ, û»öÁõ ¹× »ê¼Ò¿ä¹ý¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â µ¿¸Æ Àú»ê¼ÒÁõ µîÀ» Ư¡À¸·Î ÇÑ´Ù.
  • adaptation syndrome
    ÀûÀÀÁõÈıº, Á¶ÀýÁõÈıº
    »ýü¿¡ ¿Ü·ÂÀÌ °¡ÇØÁö¸é, ºÎ½Å ÇÇÁú°è, ³úÇϼöü°¡ Ȱµ¿ÇÏ¿© ºÎ½Å ÇÇÁú È£¸£¸óÀÌ °ú·® ºÐºñµÇ¾î ¿Ü·Â¿¡ ÀúÇ×Çϴµ¥, ÀÌ È°µ¿ÀÇ Á¤µµ¿¡ µû¶ó °¢Á¾ ÁúȯÀÌ À¯¹ßµÈ´Ù´Â °³³ä.
  • adrenal Cushing's syndrome
    ºÎ½Å Äí½Ì ÁõÈıº
    °úÀ×ÀÇ ÄÚ¸£Æ¼ÄÚÀ̵忡 ÀÇÇØ ³ªÅ¸³ª´Â Áõ»óÀ» ÀÏÄÃÀ¸¸ç ´ë°³ ´çÁú ÄÚ¸£Æ¼ÄÚÀ̵åÀÇ °ú¿ë·®¿¡ ÀÇÇØ »ý±â°í ºÎ½Å ÇÇÁúÀÇ ÄÚ¸£Æ¼ÄÚÀÌµå »ý»ê¿¡ ÀÇÇÑ °æ¿ì´Â µå¹°´Ù. ÀÚ¿¬ ¹ß»ýÀÇ Äí½Ì ÁõÈıºÀº ¼ºÀÎÀÇ °æ¿ì ´ÙÀ½°ú °°Àº °¡´É¼ºÀÌ ÀÖ´Ù. 1
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
concentration cell <physiology> An electrochemical cell in which the two compartments contain the same solutions, but at different concentrations.
(05 Jan 1998)
concentration-effect curve <pharmacology> This is a graph produced to show the relationship between the exposure concentration of a drug or other foreign chemical and the magnitude of the graded effect that it produces.
(05 Jan 1998)
concentration gradient <chemistry> A column of liquid in which the density varies continually with position, usually as a consequence of variation of concentration of a solute.
Such gradients may be established by progressive mixing of solutions of different density as for example: sucrose gradients) or by centrifuge induced redistribution of solute (as for caesium chloride gradients).
Density gradients are widely used for centrifugal and gravity induced separations of cells, organelles and macromolecules. The separations may exploit density differences between particles or primarily differences in size, in which latter case the function of the gradient is chiefly to stabilise the liquid column against mixing.
(12 Jan 1998)
concentration-response curve <pharmacology> This is a graph produced to show the relation between the exposure concentration of a drug (or other chemical) and the degree of response it produces, as measured by the percentage of the exposed population showing a defined, often quantal, effect.
(05 Jan 1998)
critical concentration <chemistry> The minimum concentration of units needed before a biological polymer will form.
Examples of biopolymers are microtubules from tubulin units, polypeptides from amino acid units, polysaccharides from simple sugar units, etc.
(09 Oct 1997)
critical dissolved oxygen concentration <biology> The minimum concentration of oxygen in the water needed for the growth of a culture which has been submerged, where oxygen is the limiting factor to the growth of the culture.
(09 Oct 1997)
critical micelle concentration The concentration at which an amphipathic molecule (e.g., a phospholipid) will form a micelle.
(05 Mar 2000)
immediately dangerous to life concentration <radiobiology> This is a regulatory value defined as the maximum exposure concentration in the workplace from which one could escape within 30 minutes without suffering symptoms which would interfere with escaping and without suffering any irreversible health effects.
(04 Nov 1997)
osmolar concentration The concentration of osmotically active particles in solution expressed in terms of osmoles of solute per liter of solution. Osmolality is expressed in terms of osmoles of solute per kilogram of solvent.
(12 Dec 1998)
urinary concentration test A test of renal tubular function whereby the patient is dehydrated for a measured period of time and the specific gravity of the urine is subsequently determined.
(05 Mar 2000)
Fishberg concentration test A test of renal water conservation; after overnight fluid deprivation, morning urine samples are collected and specific gravity is measured.
(05 Mar 2000)
Aarskog-Scott syndrome A syndrome of ocular hypertelorism, anteverted nostrils, broad upper lip, saddle-bag scrotum, and laxity of ligaments resulting in genu recurvatum, flat feet, and hyperextensible fingers; X-linked and autosomal dominant forms.
Synonym: Aarskog-Scott syndrome.
(05 Mar 2000)
Aarskog syndrome <syndrome> Grier et al. (1983) reported father and 2 sons with typical Aarskog syndrome, including short stature, hypertelorism, and shawl scrotum.
They tabulated the findings in 82 previous cases. X-linked recessive inheritance has been repeatedly suggested. The family reported by Welch (1974) had affected males in 3 consecutive generations. Thus, there is either genetic heterogeneity or this is an autosomal dominant with strong sex-influence and possibly ascertainment bias resulting from use of the shawl scrotum as a main criterion. Stretchable skin was present in the cases of Grier et al. (1983). Teebi et al. (1993) reported the case of an affected mother and 4 sons (including a pair of monozygotic twins) by 2 different husbands. They suggested that the manifestations were as severe in the mother as in the sons and that this suggested autosomal dominant inheritance. Actually, the mother seemed less severely affected, compatible with X-linked inheritance.
Clinical signs: Mild to moderate short stature,normocephaly, Widow's peak hair, maxillary hypoplasia, broad nasal bridge, anteverted nostrils, long philtrum, broad upper lip, curved linear dimple below the lower lip, hypertelorism, ptosis, down-slanted palpebral fissures, ophthalmoplegia, strabismus, hyperopic astigmatism, large cornea, floppy ears, lop-ears,cleft lip/palate, shawl scrotum, saddle-bag scrotum, cryptorchidism, brachydactyly, digital contractures, clinodactyly, mild syndactyly, transverse palmar crease, lymphoedema of the feet, ligamentous laxity, osteochondritis dissecans, proximal finger joint hyperextensibility, flexed distal finger joints, genu recurvatum, flat feet, stretchable skin, cervical spine hypermobility, odontoid anomaly, macrocytic anaemia, hemochromatosis, hepatomegaly, portal cirrhosis, imperforate anus, rectoperineal fistula, interstitial pulmonary disease, sternal deformity.
Inheritance: Sex-influenced autosomal dominant form, also X-linked form.
(05 Aug 1998)
abdominal muscle deficiency syndrome <syndrome> Congenital absence (partial or complete) of abdominal muscles, in which the outline of the intestines is visible through the protruding abdominal wall; in males, genitourinary anomalies (urinary tract dilation and cryptorchidism) are also found; genetics unclear.
(05 Mar 2000)
abstinence syndrome <syndrome> A constellation of physiologic changes undergone by persons or animals who have become physically dependent on a drug or chemical due to prolonged use at elevated doses, but who are abruptly deprived of that substance. The abstinence syndrome varies with the drug to which dependence has developed. Generally the effects observed are in an opposite direction from those produced by the drug; e.g., the withdrawal syndrome from central nervous system depressants such as barbiturates and benzodiazepines consists of insomnia, restlessness, tremulousness, hallucinations, and, in the extreme, tonic-clonic convulsions which may prove fatal. The onset time and severity of the abstinence syndrome depend upon how rapidly the drug disappears from the body.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • camp
    ¾ß¿µ(Áö),õ¸·Áý´Ü,»êÀå,µ¿Áö
  • Camp David
    Ä·ÇÁ µ¥À̺ñµå(¹Ì±¹ MarylandÁß¿¡ ÀÖ´Â ¹Ì±¹ ´ëÅë·É Àü¿ë º°Àå)
  • camp
    (»ê,¹Ù´å°¡ÀÇ) Ä·ÇÁÀå;¾ß¿µÁö(±º´ë.º¸À̽ºÄ«¿ìÆ®.¿©ÇàÀÚÀÇ);ÀÓ½ÃÁÖµÐÁö;¸·»ç;¾ß¿µÃµ¸·;¾ß¿µ´ë;ÃâÁ¤±º;Ä·ÇÁ(»ýȰ);±º´ë»ýȰ;º´¿ª;õ¸·»ýȰ;Áø¿µ;µ¿Áö(ÁÖÀÇ.Á¾±³µîÀÇ);±×·ì;ÁöºÎ;ºÐȸ;(Æ÷·Î)¼ö¿ë¼Ò;»êÀå;°¡ÃàÀÇ ÁýÇÕÀå;õ¸·À» Ä¡´Ù;¾ß¿µÇÏ´Ù(½ÃŰ´Ù);²Ù¹Ì´Â (°ÅÁþ)ŵµ(¸öÁþ);
  • camp bed
    (Á¢À»¼ö ÀÖ´Â)¾ß¿Ü¿ë(¾ßÀü) ħ´ë
  • camp chair
    (Á¢À» ¼ö ÀÖ´Â)°£Æí ÀÇÀÚ
  • camp counselor
    (¾î¸°À̸¦ À§ÇÑ)Ä·ÇÁ ÁöµµÀÚ
  • camp fever
    ¾ß¿µÁö¿¡ ¹ß»ýÇÏ´Â ¿­º´(ƯÈ÷ ¹ßÁø ƼǪ½º)
  • camp follower
    ºñÀüÅõ Á¾±ºÀÚ(»óÀÎ.À§¾ÈºÎ µî);ÃßÁ¾ÀÚ;»ç¸®»ç¿å¹Ý »ý°¢ÇÏ´Â Á¤Ä¡°¡
  • camp meeting
    ¾ß¿Ü Áýȸ(¼öÀϰ£ ±âµµ.¼³±³ µîÀ» ÇÏ´Â)
  • day camp
    ÁÖ°£¿¡¸¸ ÇÏ´Â ¾î¸°À̸¦ À§ÇÑ Ä·ÇÁ
  • detention camp
    Æ÷·Î ¼ö¿ë¼Ò;¾ï·ù¼Ò
  • health camp
    º¸°Ç Ä·ÇÁ(Çã¾à¾Æ¸¦ À§ÇÑ ¿Á¿Ü ÈÆ·Ã ½Ã¼³)
  • high camp
    ¿¹¼úÀûÀ¸·Î ÁøºÎÇÑ °ÍÀ» ÀǵµÀûÀ¸·Î ÀÌ¿ëÇϱâ
  • holiday camp
    (ÇØº¯ÀÇ)ÈÞ°¡¿ë Ä·ÇÁÀå;Çà¶ôÁö
  • internment camp
    Æ÷·Î ¼ö¿ë¼Ò(¹Ì)detention camp
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á